Coenzyme Q10 in breast cancer care

References

• Bahar M , KhaghaniS, PasalarPet al. Exogenous coenzyme Q10 modulates MMP-2 activity in MCF-7 cell line as a breast cancer cellular model. Nutr. J.9, 62 (2010).
   PubMed Web of Science ®Google Scholar
• Cooney RV , DaiQ, GaoYTet al. Low plasma coenzyme Q(10) levels and breast cancer risk in Chinese women. Cancer Epidemiol. Biomarkers Prevent.20(6), 1124–1130 (2011).
   PubMed Web of Science ®Google Scholar
• Complementary treatments highlighted at recent meeting. Oncology (Williston Park, N.Y.)13(2), 166 (1999).
   PubMedGoogle Scholar
• Hill GJ , ShriverBJ, ArnettDB. Examining intentions to use CoQ10 amongst breast cancer patients. Am. J. Health Behav.30(3), 313–321 (2006).
   PubMed Web of Science ®Google Scholar
• Sivak LA , Askol’skiiAV, Lial’kinSA, KlimanovM, MaidanevichNN, KasapNV. Cardiotoxicity of conservative treatment of solid tumors. Lik. Sprava (3–4), 51–59 (2011).
   PubMedGoogle Scholar
• Portakal O , OzkayaO, Erden InalM, BozanB, KosanM, SayekI. Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clin. Biochem.33(4), 279–284 (2000).
   PubMed Web of Science ®Google Scholar
• Sinatra ST . “Care,” cancer and coenzyme Q10. J. Am. Coll. Cardiol.33(3), 897–899 (1999).
   PubMed Web of Science ®Google Scholar
• Greenlee H , ShawJ, LauYK, NainiA, MaurerM. Lack of effect of coenzyme q10 on doxorubicin cytotoxicity in breast cancer cell cultures. Integr. Cancer Ther.11(3), 243–250 (2012).
   PubMed Web of Science ®Google Scholar
• Perumal SS , ShanthiP, SachdanandamP. Augmented efficacy of tamoxifen in rat breast tumorigenesis when gavaged along with riboflavin, niacin, and CoQ10: effects on lipid peroxidation and antioxidants in mitochondria. Chem. Bio. Interact.152(1), 49–58 (2005).
   PubMed Web of Science ®Google Scholar
• Lockwood K , MoesgaardS, FolkersK. Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochem. Biophys. Res. Communs.199(3), 1504–1508 (1994).
   PubMed Web of Science ®Google Scholar
• Lockwood K , MoesgaardS, HaniokaT, FolkersK. Apparent partial remission of breast cancer in ‘high risk’ patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol. Aspects Med.15(Suppl.), s231–s240 (1994).
   PubMed Web of Science ®Google Scholar
• Lockwood K , MoesgaardS, YamamotoT, FolkersK. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochem. Biophys. Res. Communs.212(1), 172–177 (1995).
   PubMed Web of Science ®Google Scholar
• Premkumar VG , YuvarajS, VijayasarathyK, GangadaranSG, SachdanandamP. Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy. Biol. Pharm. Bull.30(2), 367–370 (2007).
   PubMed Web of Science ®Google Scholar
• Premkumar VG , YuvarajS, ShanthiP, SachdanandamP. Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy. Br. J. Nutr.100(6), 1179–1182 (2008).
   PubMed Web of Science ®Google Scholar
• Premkumar VG , YuvarajS, SathishS, ShanthiP, SachdanandamP. Anti-angiogenic potential of coenzymeQ10, riboflavin and niacin in breast cancer patients undergoing tamoxifen therapy. Vascul. Pharmacol.48(4–6), 191–201 (2008).
   PubMed Web of Science ®Google Scholar
• Premkumar VG , YuvarajS, VijayasarathyK, GangadaranSG, SachdanandamP. Serum cytokine levels of interleukin-1beta, −6, −8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin. Basic Clin. Pharmacol. Toxicol.100(6), 387–391 (2007).
   PubMed Web of Science ®Google Scholar
• Yuvaraj S , PremkumarVG, VijayasarathyK, GangadaranSG, SachdanandamP. Augmented antioxidant status in tamoxifen treated postmenopausal women with breast cancer on co-administration with coenzyme Q10, niacin and riboflavin. Cancer Chemother. Pharmacol.61(6), 933–941 (2008).
   PubMed Web of Science ®Google Scholar
• Yuvaraj S , PremkumarVG, ShanthiP, VijayasarathyK, GangadaranSG, SachdanandamP. Effect of coenzyme Q(10), riboflavin and niacin on tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles. Breast Cancer Res. Treat.114(2), 377–384 (2009).
   PubMed Web of Science ®Google Scholar
• Yuvaraj S , PremkumarVG, VijayasarathyK, GangadaranSG, SachdanandamP. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins. Clin. Biochem.40(9–10), 623–628 (2007).
   PubMed Web of Science ®Google Scholar
• Sachdanandam P . Antiangiogenic and hypolipidemic activity of coenzyme Q10 supplementation to breast cancer patients undergoing tamoxifen therapy. Biofactors32(1–4), 151–159 (2008).
   PubMed Web of Science ®Google Scholar
• Lesser GJ , CaseD, StarkNet al. A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer. J. Support. Oncol.11(1), 31–42 (2013).
   PubMedGoogle Scholar
• Iwase S , KawaguchiT, YotsumotoDet al. Efficacy and safety of an amino acid jelly containing coenzyme Q10 and L-carnitine in controlling fatigue in breast cancer patients receiving chemotherapy: a multi-institutional, randomized, exploratory trial (JORTC-CAM01). Support. Care Cancer24(2), 637–646 (2016).
   PubMed Web of Science ®Google Scholar
• Bjorklund G . The Adjuvant Nutritional Intervention in Cancer (ANICA) trial. Nutr. Cancer67(8), 1355–1358 (2015).
   PubMed Web of Science ®Google Scholar
• Chai W , CooneyRV, FrankeAAet al. Plasma coenzyme Q10 levels and postmenopausal breast cancer risk: the multiethnic cohort study. Cancer Epidemiol. Biomarkers Prevent.19(9), 2351–2356 (2010).
   PubMed Web of Science ®Google Scholar